Nanoform and Celanese demonstrate enhanced drug delivery through smaller implants
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
The new lab will enable the Group to accelerate its efforts in this area, building new competencies and capabilities, as well as strengthening Solvay’s ability to develop breakthroughs in biodegradable-by-design solutions.
Agreement provides customers in the majority of Europe* access to supply through Univar Solutions distribution network
Construction will begin this year with the new capacity anticipated by 2025
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
elanese now offers Zytel Resin, Hytrel TPC, Crastin PBT and Micromax Electronic Inks and Paste following its 2022 acquisition of the majority of the Mobility & Materials (M&M) business from DuPont
One thousand times more soluble than L-cystine at neutral pH
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
Subscribe To Our Newsletter & Stay Updated